MC-1288

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameMC-1288
Drug Alias Name20-Epi-1,25-dihydroxyvitamin-D3
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunosuppressantsVitamin D receptor agonists
TargetsVitamin D receptor
Therapy Area/IndicationsRejection of organ transplantationRejection of renal transplantationAutoimmune Diseases +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwedenDenmarkFinland
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLeo Pharma A/S
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLeo Pharma A/S +[2] 
Active IndicationsN/A
Inactive IndicationsRejection of organ transplantationRejection of renal transplantationAutoimmune Diseases +[5] 

Other Information

ATC CodeN/A
Related LinksN/A